1-800 Contacts Acquires Ditto
It will combine Premium Vision, 6over6 and Ditto
into a separate business unit focused on providing
IMI 2021 YEARLY DIGEST
The International Myopia Institute (IMI) Yearly Digest
highlights new research considered to be of importance
since the publication of the first series of IMI white papers.
Making Cataract Surgery Child’s Play
The FDA’s first approved drop for the prevention of
intraoperative miosis and reduction of postoperative pain
in pediatric patients undergoing cataract surgery has arrived. But does it warrant the excitement?
Study sheds new light on the function of a sight-saving growth factor
Researchers at the National Eye Institute (NEI) have
determined how certain short protein fragments,
called peptides, can protect neuronal cells found in the light-sensing retina layer at the back of the eye.
New Era Arrives in Glaucoma Medication, With Transformative Tech
Market Scope estimates pharmaceutical companies
will earn $1.9 billion from glaucoma medications
in the US in 2021, after discounts and rebates, and $4.8 billion worldwide.
Steady Growth, New Technologies Will Drive Retinal Surgery Device Market to $1.36 Billion in 2026
The retinal surgical device market is expected
to total more than $1.14 billion in 2021,
with revenue rising to nearly $1.36 billion in 2026, according to a Market Scope report.